A Phase 1b, Multicenter, Dose-Escalation Study of Subasumstat (TAK-981) in Combination with Pembrolizumab in Patients (pts) with Advanced Solid Tumors.
Journal of Clinical Oncology(2022)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined